Testing effectiveness (Phase 2)Ended earlyNCT02889861What this trial is testingIMCgp100-401 Rollover StudyWho this might be right forMalignant Melanoma Immunocore Ltd 3
Testing effectiveness (Phase 2)Study completedNCT00365287What this trial is testingCombination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerWho this might be right forBreast CancerKidney CancerLeukemia+3 more Masonic Cancer Center, University of Minnesota 148
Early research (Phase 1)Study completedNCT03725436What this trial is testingALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT03428802What this trial is testingPembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic InstabilityWho this might be right forBRCA1 Gene MutationBRCA2 Gene MutationLocally Advanced Solid Neoplasm+17 more Rutgers, The State University of New Jersey 21
Early research (Phase 1)WithdrawnNCT00661336What this trial is testingA Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant MelanomaWho this might be right forMelanoma (Skin) Duke University
Testing effectiveness (Phase 2)Study completedNCT00706030What this trial is testingStudy Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast CancerWho this might be right forBreast CancerAdvanced Malignant Solid Tumors Puma Biotechnology, Inc. 92
Testing effectiveness (Phase 2)Ended earlyNCT00060710What this trial is testingCP-461 in the Treatment of Patients With Advanced MelanomaWho this might be right forMalignant Melanoma Astellas Pharma Inc 35
Early research (Phase 1)Study completedNCT01655225What this trial is testingLY3023414 in Participants With Advanced CancerWho this might be right forAdvanced CancerMetastatic CancerNon-Hodgkin's Lymphoma+3 more Eli Lilly and Company 156
Large-scale testing (Phase 3)Study completedNCT00016263What this trial is testingDacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant MelanomaWho this might be right forMelanoma (Skin) Genta Incorporated
Early research (Phase 1)Temporarily pausedNCT01841463What this trial is testingStudy of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF MutationWho this might be right forAdvanced or Inoperable Malignant Melanoma With BRAF Mutation Piramal Enterprises Limited 100
Not applicableStudy completedNCT00974610What this trial is testingStudy of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.Who this might be right forBreast CancerColorectal CancerLung Cancer+2 more Cancer Trials Ireland 803
Early research (Phase 1)Active Not RecruitingNCT04013685What this trial is testingPrecision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+3 more Orca Biosystems, Inc. 155
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Post-approval studies (Phase 4)Active Not RecruitingNCT02068196What this trial is testingA National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.Who this might be right forMalignant Melanoma Oslo University Hospital 150
Early research (Phase 1)Study completedNCT03590054What this trial is testingAbexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesWho this might be right forStage III Cutaneous MelanomaStage IV Cutaneous MelanomaLocally Advanced Melanoma+18 more Rahul Aggarwal 35
Very early researchWithdrawnNCT05238831What this trial is testingSMMART Adaptive Clinical Treatment (ACT) TrialWho this might be right forAdvanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+14 more OHSU Knight Cancer Institute
Early research (Phase 1)Ended earlyNCT00088647What this trial is testingStudy Evaluating MST-997 in Advanced Malignant Solid TumorsWho this might be right forNeoplasms Wyeth is now a wholly owned subsidiary of Pfizer
Testing effectiveness (Phase 2)Study completedNCT04072952What this trial is testingA Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Arvinas Estrogen Receptor, Inc. 217
Early research (Phase 1)UnknownNCT03903458What this trial is testingTinostamustine and Nivolumab in Advanced MelanomaWho this might be right forMalignant Melanoma Markus Joerger 21
Early research (Phase 1)Active Not RecruitingNCT04704661What this trial is testingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialWho this might be right forAdvanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more National Cancer Institute (NCI) 51